RecruitingNCT06330597

NIVIA-Hemodynamics

Noninvasive Versus Invasive Assessment of Hemodynamics in the Cardiac Intensive Care Unit

Sponsor

University Health Network, Toronto

Enrollment

100 participants

Start Date

Jul 17, 2021

Study Type

OBSERVATIONAL

Conditions

Heart Failure Cardiogenic Shock Shock Hemodynamic Instability

Summary

This is an investigator-initiated, single-center, single-arm prospective study to compare non-invasive hemodynamic assessment using transthoracic echocardiography (TTE) and lung ultrasound (LUS) and hemodynamic assessment using PAC. Patients who have been hemodynamically assessed using PAC will be invited to participate. Each patient will undergo TTE and LUS immediately after first invasive assessment, and again daily after PAC assessments.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study — called NIVIA-Hemodynamics — is investigating how to better measure and monitor blood flow and heart function in critically ill patients in the cardiac intensive care unit (CICU) using a specialized catheter placed in the heart's blood vessels (a pulmonary artery catheter, or PAC). Researchers want to understand how hemodynamic measurements (how blood moves through the heart and lungs) can guide treatment decisions. **You may be eligible if:** - You are admitted to the cardiac intensive care unit (CICU) - A pulmonary artery catheter has been placed in you as part of your standard medical care **You may NOT be eligible if:** - You are already enrolled in another clinical trial with an active treatment arm Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTEchocardiography and lung ultrasound

All patients will undergo non-invasive echocardiogram and lung ultrasound at times of assessment of hemodynamic parameters as needed by usual clinical management.

Locations(1)

University Health Network

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06330597

Related Trials

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management

NCT074022391 location

The Salt Study for Heart Failure

NCT075605921 location